Matthew R Weir Selected Research

patiromer

9/2021	Safety and Tolerability of the Potassium Binder Patiromer From a Global Pharmacovigilance Database Collected Over 4 Years Compared with Data from the Clinical Trial Program.
1/2018	Effect of Patiromer on Hyperkalemia Recurrence in Older Chronic Kidney Disease Patients Taking RAAS Inhibitors.
1/2018	Hyperkalemia in the Hypertensive Patient.
1/2018	Long-term effects of patiromer for hyperkalaemia treatment in patients with mild heart failure and diabetic nephropathy on angiotensin-converting enzymes/angiotensin receptor blockers: results from AMETHYST-DN.
4/2017	Expert Panel Recommendations for the Identification and Management of Hyperkalemia and Role of Patiromer in Patients with Chronic Kidney Disease and Heart Failure.
1/2017	Effectiveness of patiromer in the treatment of hyperkalemia in chronic kidney disease patients with hypertension on diuretics.
1/2017	Patiromer Lowers Serum Potassium When Taken without Food: Comparison to Dosing with Food from an Open-Label, Randomized, Parallel Group Hyperkalemia Study.
1/2016	Treatment with patiromer decreases aldosterone in patients with chronic kidney disease and hyperkalemia on renin-angiotensin system inhibitors.
12/2015	Patiromer induces rapid and sustained potassium lowering in patients with chronic kidney disease and hyperkalemia.
10/2015	Effect of patiromer on reducing serum potassium and preventing recurrent hyperkalaemia in patients with heart failure and chronic kidney disease on RAAS inhibitors.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Matthew R Weir Research Topics

Disease

64	Hypertension (High Blood Pressure) 01/2022 - 03/2001
59	Chronic Renal Insufficiency 04/2022 - 04/2002
31	Type 2 Diabetes Mellitus (MODY) 01/2022 - 05/2003
21	Chronic Kidney Failure (Chronic Renal Failure) 07/2020 - 05/2002
20	Kidney Diseases (Kidney Disease) 01/2022 - 01/2002
20	Hyperkalemia 10/2021 - 01/2002
20	Heart Failure 01/2021 - 01/2002
15	Cardiovascular Diseases (Cardiovascular Disease) 01/2019 - 11/2004
13	Fibrosis (Cirrhosis) 04/2021 - 01/2002
13	Albuminuria 01/2021 - 01/2006
9	Atherosclerosis 04/2022 - 05/2002
9	Anemia 01/2021 - 08/2011
8	Proteinuria 04/2016 - 10/2003
7	Atrial Fibrillation 12/2021 - 10/2017
7	Stroke (Strokes) 11/2021 - 06/2006
7	Infections 04/2021 - 08/2002
7	Myocardial Infarction 05/2018 - 02/2003
6	Inflammation (Inflammations) 01/2021 - 05/2002
6	Diabetes Mellitus 01/2018 - 06/2003
6	Diabetic Nephropathies (Diabetic Nephropathy) 01/2018 - 05/2007
6	Isolated Systolic Hypertension 04/2016 - 03/2001
5	Obesity 12/2021 - 04/2004
5	Hemorrhage 11/2021 - 10/2017
5	Acute Kidney Injury (Acute Renal Failure) 01/2021 - 01/2008
5	Hypokalemia 01/2020 - 12/2009
5	Renal Insufficiency (Renal Failure) 01/2020 - 05/2003
5	Edema (Dropsy) 10/2008 - 01/2002
4	Heart Diseases (Heart Disease) 01/2017 - 02/2008
4	Arthritis (Polyarthritis) 12/2012 - 01/2002
4	Vascular Diseases (Vascular Disease) 03/2012 - 05/2002
3	Ischemic Stroke 01/2020 - 10/2017
3	Necrosis 11/2019 - 06/2015
3	Hyperuricemia 12/2017 - 03/2010
3	Hypotension (Low Blood Pressure) 03/2013 - 04/2010
2	Prediabetic State (Prediabetes) 01/2022 - 09/2007
2	Cognitive Dysfunction 01/2022 - 05/2007
2	Hemorrhagic Stroke 11/2021 - 09/2009

Drug/Important Bio-Agent (IBA)

27	Antihypertensive Agents (Antihypertensives)IBA 08/2020 - 03/2001
25	CreatinineIBA 04/2021 - 04/2002
22	PotassiumIBA 10/2021 - 01/2005
20	Angiotensin Receptor AntagonistsIBA 01/2019 - 06/2003
20	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2019 - 03/2001
19	SodiumIBA 09/2021 - 01/2005
12	patiromerIBA 09/2021 - 01/2015
12	DiureticsIBA 01/2021 - 03/2001
12	Hydrochlorothiazide (Esidrix)FDA LinkGeneric 05/2013 - 09/2005
10	Biomarkers (Surrogate Marker)IBA 04/2022 - 11/2004
10	Pharmaceutical PreparationsIBA 01/2022 - 05/2003
10	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 07/2004
10	SaltsIBA 01/2019 - 01/2002
9	Amlodipine (Norvasc)FDA LinkGeneric 05/2013 - 06/2002
8	Warfarin (Coumadin)FDA LinkGeneric 12/2021 - 06/2006
8	ElectrolytesIBA 10/2021 - 01/2005
8	Proteins (Proteins, Gene)FDA Link 01/2021 - 10/2003
7	RivaroxabanIBA 12/2021 - 01/2016
7	AlbuminsIBA 01/2021 - 07/2003
7	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2020 - 01/2002
6	CanagliflozinIBA 01/2022 - 09/2014
6	Hemoglobins (Hemoglobin)IBA 01/2021 - 07/2003
6	EnzymesIBA 01/2018 - 01/2002
5	Hypoglycemic Agents (Hypoglycemics)IBA 01/2022 - 09/2009
5	LipidsIBA 01/2022 - 07/2012
5	SymportersIBA 01/2020 - 09/2014
5	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2019 - 07/2003
5	ReninIBA 01/2018 - 02/2008
5	AngiotensinsIBA 01/2018 - 01/2008
5	MineralsIBA 10/2016 - 11/2011
5	Angiotensin IIIBA 02/2016 - 07/2003
5	benazepril (Briem)FDA LinkGeneric 02/2013 - 06/2002
5	oxidized low density lipoproteinIBA 07/2012 - 11/2006
5	Valsartan (Vals)FDA Link 05/2011 - 09/2005
5	LDL CholesterolIBA 05/2010 - 11/2006
5	SandIBA 05/2010 - 11/2006
4	HematinicsIBA 01/2021 - 03/2009
4	Uric Acid (Urate)IBA 08/2019 - 09/2008
4	AldosteroneIBA 01/2018 - 10/2003
4	PolymersIBA 01/2018 - 07/2015
4	Iothalamic Acid (Iotalamic Acid)FDA Link 01/2018 - 04/2014
4	ThiazidesIBA 01/2014 - 09/2003
4	Diclofenac (SR 38)FDA LinkGeneric 12/2012 - 10/2003
4	Losartan (Cozaar)FDA LinkGeneric 05/2011 - 07/2003
3	Fibroblast Growth Factor-23IBA 01/2021 - 07/2012
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2019 - 05/2007
3	CholesterolIBA 01/2019 - 07/2004
3	LDL Lipoproteins (beta Lipoproteins)IBA 01/2018 - 10/2009
3	C-Reactive ProteinIBA 01/2018 - 05/2002
3	Cystatin CIBA 01/2018 - 04/2014
3	Sodium-Glucose Transporter 2 InhibitorsIBA 06/2016 - 01/2016
3	Olmesartan Medoxomil (Votum)FDA Link 03/2013 - 01/2011
3	EtoricoxibIBA 12/2012 - 04/2009
3	CalciumIBA 11/2011 - 03/2001
3	aliskiren FDA Link 12/2010 - 07/2007
3	Renin InhibitorsIBA 09/2010 - 07/2007
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 06/2006 - 01/2002

Therapy/Procedure

51	Therapeutics 01/2022 - 03/2001
12	Kidney Transplantation 01/2021 - 04/2004
6	Transplantation 01/2018 - 12/2008
4	Glycemic Control 11/2020 - 05/2007
4	Liver Transplantation 01/2018 - 07/2012
3	Drug Tapering 12/2015 - 09/2003